General Archive
![](https://www.lifearc.org/wp-content/uploads/2024/01/image-1.png)
-
Articles & blogs
International Women’s Day 2023
Tips on career advancement, from some of LifeArc’s incredible women
-
Articles & blogs
Rare Disease Day 2023 – Robbie’s story
Robbie has a rare genetic neurodegenerative disease known as AP-4 Hereditary Spastic Paraplegia (AP-4 HSP) subtype SPG47.
-
News releases
£1 million awarded to develop cutting-edge therapies for motor neuron disease
London, 24 January 2023: Medical research charity LifeArc, the Motor Neurone Disease Association (MND Association) and the My Name’5 Doddie…
-
News releases
LifeArc portfolio company RQ Bio’s antibody enters clinical trials
The first of RQ Bio’s discovered monoclonal antibodies to prevent COVID-19 in vulnerable patients has entered clinical trials.
-
Articles & blogs
2022 wrapped – our highlights from a pivotal year
We’ve seen some exciting scientific progress, forged new partnerships and launched some new landmark initiatives.
-
News releases
LifeArc partners with EMBARC to improve healthcare for people living with bronchiectasis
Three-year partnership to improve healthcare for thousands of people across Europe living with bronchiectasis.
-
Articles & blogs
MND Collaborative Partnership cautiously welcomes new Government funding
We cautiously welcome the Government’s announcement on how their £50m commitment into MND research will be spent.
-
News releases
LifeArc announces £10m funding call for new chronic respiratory infection therapies
First major funding call announced as part of our £100m Chronic Respiratory Infection Translational Challenge
-
News releases
£100m programme to transform care for people living with chronic lung conditions
More than 300,000 people in the UK are living with bronchiectasis and more than 10,000 have been diagnosed with cystic…
-
News releases
LifeArc funds home monitoring trials for people with chronic respiratory conditions
Trials will examine the impact of home monitoring and machine learning decision support algorithms for people with CF and bronchiectasis.
-
News releases, Ventures funding
LifeArc Ventures invests in Surgery Hero, world’s first digital coaching clinic for patients
Seed funding will be used to scale the solution through the application of machine learning
-
Articles & blogs, Ventures funding
AbbVie acquires LifeArc portfolio company DJS Antibodies
AbbVie will pay DJS shareholders approximately $255 million in cash at closing for the acquisition of DJS